ClinicalTrials.Veeva

Menu

Gastrointestinal Manifestations Among Patients With COVID19

A

Assiut University

Status

Completed

Conditions

Covid19

Study type

Observational

Funder types

Other

Identifiers

NCT04544150
COVID19 and GUT

Details and patient eligibility

About

many patients with confirmed infection with COVID-19 suffer from different symptoms and signs of gastrointestinal symptoms

Full description

many patients with COVID1-9 infection experienced many intestinal symptoms mainly abdominal pain, vomiting, and diarrhea. This study aimed to assess the frequency of GIT manifestations among patients with COVID-19 and its impact on the outcome

Enrollment

220 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all patients with COVID19

Exclusion criteria

  • patient refusal to participate in the study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems